英文别名 |
Hydroxypropyl Methyl Cellulose Phthalate;1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine;HP55;Hydroxypropyl Methylcellulose phthalate 50;Hydroxypropyl methylcellulose phthalate 55;IMIQUIMOD;Aldara;Zyclara;1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine;Beselna;1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine;4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline;4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline;R 837;Imiquimod acetate;S 26308;C14H16N4;1-isobutylimidazo[4,5-c]quinolin-4-amine;P1QW714R7M;1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine;1H-Imidazo[4,5-c]quinolin-4;FT-0602727;KS-5218;NCGC00070736-03;BRD-K26657438-001-01-2;CHEBI:36704;TMX 101;MTD-39;1H-Imidazo[4, 1-(2-methylpropyl)-;1-(2-methylpropyl)-1Himidazo[4,5-c]quinolin-4-amine;D02500;SR-01000611320-2;NCGC00070736-02;Cellulose, hydrogen 1,2-benzenedicarboxylate, 2-hydroxypropyl methyl ether;SCHEMBL26136;Zartra;CCG-208015;NSC759651;S26308;DTXCID5021047;CAS-99011-02-6;IMIQUIMOD [WHO-DD];NSC 759651;NSC741062;NCGC00070736-04;IMIQUIMOD [EMA EPAR];MLS000083577;s1211;1-isobutyl-1H-imidazo[4,5-c]quinoline-4-amine;AB00399298-06;9050-31-1;AKOS005507352;(Hydroxypropyl)methyl cellulose phthalate;UNII-P1QW714R7M;IMIQUIMOD [VANDF];Imiquimod, >=98% (HPLC), solid;IMIQUIMOD [USP-RS];SY017571;1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-ylamine;99011-02-6;Zyclara (TN);Imiquimod (JAN/USP/INN);Q423417;IMIQUIMOD [USAN];NSC-811538;I0747;NSC 369100;IMIQUIMOD [MI];HSDB 8129;IMIQUIMOD (USP-RS);1-isobutyl-1H-imidazo [4,5-c]quinolin-4-amine;BDBM50240849;1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-;IMIQUIMOD [JAN];S-26308;BI164576;BRD-K26657438-001-13-7;IMIQUIMOD [ORANGE BOOK];HB3109;HMS2090M14;SMR000048307;AB00399298-07;AB00399298_09;1-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine;Imiquimodum;HY-B0180;Imiquimod,(S);R-837;Z2588038940;IMIQUIMOD (MART.);SR-01000611320-3;IMIQUIMOD (USP MONOGRAPH);IMIQUIMOD [USP MONOGRAPH];NSC-759651;BCP05151;Imiquimod 100 microg/mL in Acetonitrile;D06BB10;HMS3715N19;SR-01000611320;AC-529;1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-;AB00399298-05;CHEMBL1282;6T0;BIDD:GT0859;DZ-2636;EN300-6477856;Tox21_110985;NSC 741062;IMIQUIMOD [MART.];YH44175;TMX-101;Aldara (TN);A845945;1-(2-methylpropyl)-1H-imidazo[4,5-c]-quinolin-4-amine;DB00724;HMS3747A13;1-(2-methylpropyl)-1H-imidazo(4,5-c)quinolin-4-amine;Imiquimod [USAN:INN:BAN];MFCD00866946;HMS2232G07;NSC811538;Vyloma;4-Amino-1-(2-methylpropyl)-1H-imidazo(4,5-c)quinoline;Pharmakon1600-01502351;Tox21_110985_1;NS00006714;GTPL5003;NSC369100;NSC-369100;HMS3373B13;DOUYETYNHWVLEO-UHFFFAOYSA-N;Imiquimod - CAS 99011-02-6;Imiquimod- Bio-X;Imiquimod, United States Pharmacopeia (USP) Reference Standard;IMIQUIMOD [INN];1-(2-methylpropyl)-4-imidazo[4,5-c]quinolinamine;CS-2058;R837;AB00399298_08;DTXSID7041047;BRD-K26657438-003-01-8;imiquimod?;NSC-828389;NSC828389;BBL010772;BRD-K26657438-001-15-2;STK583860;4-amino- 1-isobutyl... |